Objectives: To elucidate regional differences in management of MCDA pregnancies complicated by TTTS from Facebook (FB) group members. Methods: This was a cross-sectional survey of members of a Facebook (FB) group called ''MoDi Twins''. REDCAP survey was posted for five days with daily reminders. Participants were collected through ''snowballing,'' whereby individuals shared the survey to assist with recruiting. Data was analysed using Stata to explore provider type, frequencies of ultrasound screening, treatments and pregnancy outcomes. Categorical variables were analysed using Chi-squared using a p-value of < 0.05. Results: The survey was completed by 2,169 (63% of clicks) subjects, of which 486 (22.4%) were complicated by TTTS. Eighty (16.5%) were diagnosed <16 weeks, 259 (53.5%) between 17-26 weeks and 140 (28.9%) >27 weeks or during labour. Biweekly surveillance resulted in more diagnoses of TTTS at the extremes of GA, when compared to monthly surveillance: at <16 weeks (18.1% versus 8.3%, p<0.001) and > 27 weeks (31.2% versus 18.7%, p<0.001). Regarding treatment of TTTS, 206 (42.5%) had laser ablation, 33 (6.8%) had amnioreduction, and 120 (24.7%) were delivered upon diagnosis. Treatment was performed in stage 1, 2, 3, 4 and 5 in 31.4%, 21.6%, 30.0%, 11.2% and 5.8%, of cases, respectively. Method of treatment had no effect on take home baby rate (p=0.268). MFM involvement in care was associated with a higher take-home baby rate of 73.1% for both and 95.8% of at least one infant, compared to 66.6% and 81.1% with CNM or OB care (p=0.001).
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Intertwin discrepancy of middle cerebral artery peak systolic velocity (MCA PSV -) in the third trimester and pregnancy outcomes in monochorionic-diamniotic (MCDA) twins Methods: This was a retrospective cohort study of all MCDA pregnancies at a maternal fetal medicine referral centre between 1/2007-2/2017. Exclusion criteria were structural or chromosomal anomalies, intrauterine fetal demise (IUFD) < 16 weeks, or referral after development of Twin-twin transfusion syndrome (TTTS) or twin anemia polycythemia sequences (TAPS). Ultrasounds were performed biweekly from 16-37 weeks to survey umbilical artery and middle cerebral artery Dopplers. MCA PSV -was defined as the absolute difference between the twins and calculated at every visit. The primary outcome was development of TTTS, TAPS, or selective intrauterine growth restriction (sIUGR). The maximum MCA PSVin both the second and third trimester were assessed as predictors of adverse pregnancy outcomes by logistic regression analysis. Receiver operating characteristic (ROC) curves were calculated to determine the predictive value of MCA PSV -for MCDA-specific complications. Results: 143 MCDA twin pregnancies (16 were lost to follow-up) and 249 newborns met inclusion criteria: 16 (11.2%) were complicated by TTTS, seven (4.9%) were complicated by TAPS, 41 (28.7%) were complicated by sIUGR, and eight (5.6%) developed an IUFD of one twin. Mean gestational age at delivery was 34.9 weeks. Of the pregnancies with TAPS, one developed post laser ablation. Regression analysis identified maximum MCA PSV -in the third trimester as a predictor of TAPS (OR 1.15, 95% CI 1.06-1.25; p < 0.001), but not of TTTS (p = 0.486) or sIUGR (p = 0.341). Maximum MCA PSV -in the second trimester was not associated with TAPS, TTTS, or sIUGR. ROC curves identified maximum MCA PSV -in the third trimester (area under ROC curve (AUC) 0.94) as a strong predictor of TAPS, but not in the second trimester (AUC 0.56). Conclusions: Intertwin MCA PSV -in the third trimester is a strong predictor of the development of TAPS in MCDA twins.
